Hypoxia-driven lncRNA CTD-2510F5.4: a potential player in hepatocellular carcinoma’s prognostic stratification, cellular behavior, tumor microenvironment, and therapeutic response-Reference-Cited by-同舟云学术

Hypoxia-driven lncRNA CTD-2510F5.4: a potential player in hepatocellular carcinoma’s prognostic stratification, cellular behavior, tumor microenvironment, and therapeutic response

Published:2024-08-12 Issue:1 Volume:51 Page:
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Abulihaiti Zulipiya,Li Weihong,Yang Liangyu,Zhang Haihang,Du Ainong,Tang Ni,Lu Yanda,Zeng Jiangzheng

Funder

Hainan Province Clinical Medical Center

Hainan Province’s Key Research and Development Project

the National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11033-024-09826-6.pdf

Reference40 articles.

1. Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N, Chen W (2022) Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl) 135(5):584–590. https://doi.org/10.1097/CM9.0000000000002108

2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F, Global Cancer Statistics 2020 (2021) GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660

3. Wang Y, Deng B (2023) Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev 42(3):629–652. https://doi.org/10.1007/s10555-023-10084-4

4. Kotsari M, Dimopoulou V, Koskinas J, Armakolas A, Immune System and Hepatocellular Carcinoma (HCC) (2023) New insights into HCC Progression. Int J Mol Sci 24(14):11471. https://doi.org/10.3390/ijms241411471

5. Verdikt R, Thienpont B (2024) Epigenetic remodelling under hypoxia. Semin Cancer Biol 98:1–10. https://doi.org/10.1016/j.semcancer.2023.10.005